Histocompatibility Committee

Slides:



Advertisements
Similar presentations
Kidney Transplantation Committee Update John J. Friedewald, MD Committee Chair Meetings.
Advertisements

Kidney Transplantation Committee Spring Waiting time calculation - pre-registration dialysis time added 2.Candidate classification - Estimated.
Ad Hoc Disease Transmission Advisory Committee Spring 2015.
Histocompatibility Bylaws Rewrite: Phase 2 Histocompatibility Committee Fall 2014.
The Deceased Donor Kidney Allocation System
Kidney Transplantation Committee Spring Waiting time calculation - pre-registration dialysis time added 2.Candidate classification - Estimated.
Proposal to Clarify Data Submission Reporting and Documentation Requirements (Resolution 22) Membership & Professional Standards Committee (MPSC) Jonathan.
Greater Consistency in Candidate and Deceased Donor HLA Typing Requirements Across Organ Types Histocompatibility Committee Spring 2014.
1 Addressing the Term “Foreign Equivalent” in OPTN/UNOS Bylaws Membership and Professional Standards Committee Fall 2015.
Proposal to Improve UNet sm Reporting of Aborted Procedures and Non-Transplanted Organs Living Donor Committee Spring 2015.
Expanding HLA Typing Requirements (Resolution 10) Histocompatibility Committee Dolly Tyan, PhD Chair.
1 Proposal to Revise Facilitated Pancreas Allocation Policy Pancreas Transplantation Committee Fall 2015.
1 Proposal to Update the HLA Equivalency Tables Histocompatibility Committee Fall 2015.
Histocompatibility Committee Spring  Updates to Calculated Panel Reactive Antibody (CPRA)  More recent cohort used to calculate HLA and ethnic.
OPTN/UNOS HISTOCOMPATIBILITY COMMITTEE REPORT TO THE BOARD OF DIRECTORS JUNE 25-26, 2012 RICHMOND, VA Nancy L. Reinsmoen, PhD., Chair.
Kidney Transplantation Committee Spring Waiting time calculation - pre-registration dialysis time added 2.Candidate classification - Estimated.
1 OPTN/UNOS Histocompatibility Committee Fall 2015.
Histocompatibility Committee
Pediatric Transplantation Committee
Effects of New KPD Histocompatibility Policy on Refusal Rate and Transplants R Leishman1, M Aeder2, M S Leffell3, C Murphey4, N Reinsmoen5, S Saidman6,
Pediatric Transplantation Committee
Revisions to Pediatric Emergency Membership Exception
The Recipient Experience
Updates on the New Adult Heart Allocation System
Guidance on Optimizing VCA Recovery from Deceased Donors
Histocompatibility Committee
Histocompatibility Committee
OPO Committee Spring 2018.
OPO Committee Update Spring 2017.
Pediatric Transplantation Committee
OPTN Kidney Paired Donation (KPD) Histocompatibility Testing Policies
Guidance for ABO Subtyping Organ Donors for Blood Groups A and AB
OPTN/UNOS Kidney Transplantation Committee
Addressing HLA Typing Errors
Membership and Professional Standards Committee
Histocompatibility Laboratory Bylaws and Policies Guidance Document
Histocompatibility Committee
Pediatric Transplantation Committee
Membership & Professional Standards Committee
Pediatric Transplantation Committee
Changes to Hospital-Based OPO (HOPO) Voting Privileges
System Optimizations Work Group Update
Region 8: What is Possible? Topic : Systems Optimization
OPTN Kidney Paired Donation (KPD) Histocompatibility Testing Policies
OPTN Histocompatibility Committee
Kidney Transplantation Committee
Kidney Transplantation Committee
Pediatric Transplantation Committee
OPO Committee Fall 2014.
OPTN Kidney Paired Donation (KPD) Histocompatibility Testing Policies
OPTN Kidney Paired Donation (KPD) Histocompatibility Testing Policies
Thoracic Organ Transplantation Committee
Kidney Transplantation Committee
Pancreas Transplantation Committee
Kidney Transplantation Committee
Living Donor Committee
Nancy L. Reinsmoen, PhD, Chair
Living Donor Committee
Region 8 Meeting Harvey Solomon, MD
Improving the Efficiency of Organ Placement
Histocompatibility Committee
Histocompatibility Committee
OPO Committee Fall 2014.
Histocompatibility Committee
OPTN/UNOS Histocompatibility Committee
Pancreas Transplantation Committee
Histocompatibility Committee
Histocompatibility Committee
OPTN/UNOS Histocompatibility Committee
Pancreas Transplantation Committee
Presentation transcript:

Histocompatibility Committee Spring 2014

Recently Implemented Updates to Calculated Panel Reactive Antibody (CPRA) More recent cohort used to calculate HLA and ethnic frequencies Addition of HLA-C Addition of required question on Waitlist℠ for KI, K/P, PA candidates-Effective March 20, 2014 Was this candidate tested for anti-HLA antibodies? -Yes, antibodies detected -Yes, no antibodies detected -No, not tested To start, I’ll give you a quick update on several new policies and programming that UNOS recently implemented. First, effective December 5, 2013, the CPRA calculation now includes HLA and ethnic frequencies from a more recent cohort of deceased donors. And, frequencies for HLA-C are now included in the calculation. Starting on March 20, the waiting list for kidney, kidney-pancreas, and pancreas candidates will require users to answer a question about whether the candidate was tested for HLA antibodies. The question will be required for new registrations and when edits are made for existing kidney, kidney-pancreas, and pancreas candidates. The question and answer will be displayed on match runs and is intended to help the transplant team better interpret a CPRA score when making organ acceptance decisions, especially in instances where the CPRA score does not reflect whether a candidate has HLA antibodies. For instance, before HLA-C was added into the CPRA calculation, a candidate with antibodies to HLA-C could have had unacceptable antigens listed for HLA-C, but the CPRA calculation did not include those. Right now, the UNOS system does not capture DQA, DPA, or DPB, so these are not included in the current CPRA either. (The first step in getting those included into the calculation is to add these fields so we can capture data on the frequency that these are reported in the current donor pool.)

Recently Implemented Changes to Histo Bylaws—Effective Feb. 1, 2014 Notify UNOS within 7 days of change in key personnel, ubmit a personnel change application and lab coverage plan within 30 days Includes key personnel who accept additional responsibilities for more than 30 days at another histo lab Must have qualified director, tech supervisor, and clinical consultant at all times (including periods of key personnel transition) Must have written agreements with every affiliated OPO or transplant hospital Agreements must contain certain elements There are also a number of new changes to the bylaws governing histo labs in effect as of February 1. Let’s go over those and what you need to do. First, if your lab has a change in key personnel (lab director, tech supervisor, or clinical consultant), you must notify UNOS within 7 days of learning of the change. If you do not know how to notify UNOS directly, contact your regional administrator for help. After notifying UNOS, you must submit a completed personnel change application (UNOS will provide this for you) and laboratory coverage information to UNOS within 30 days. A change in key personnel now includes when the primary histo lab director accepts additional responsibilities for more than 30 days at another histo lab. And, your lab must have qualified key personnel coverage throughout any transition periods. This is all to ensure that there are qualified key personnel available to provide consultation to the OPO or transplant team. Finally, your lab must have written agreements with every transplant program or OPO that you serve. And, those agreements must address certain elements outlined in the bylaws. Please take a look at the bylaws to be sure your written agreements are in compliance. UNOS will ask for this information with any change in key personnel and new laboratory application.

Laboratory Coverage Plan Availability of key personnel List of key personnel responsibilities delegated to other staff Documentation that qualified staff are available to perform testing (24-hour coverage if DD testing for KI, K-P, or PA) If key personnel serve multiple labs, how continuous coverage is provided at each lab served Here’s a list of things that labs must provide in the laboratory coverage plan. We are looking for documentation about the availability of key personnel for facilitating organ acceptance decisions, a list of responsibilities designated to any key personnel who are being performed by someone other than the individual in that position, and documentation of key personnel coverage at all times. For labs with key personnel who serve more than one laboratory, the coverage plan must include how continuous coverage is being provided at each lab served.

Questions? Lee Ann Baxter-Lowe Committee Chair lbaxterlowe@chla.usc.edu Name Region # Representative Email Gena Boyle Committee Liaison gena.boyle@unos.org